The use of stem cells for pancreatic regeneration in diabetes mellitus

Nature Reviews Endocrinology

Volumn 9, Issue 10, 2013, Pages 598-606

  Bouwens, Luc ^a   Houbracken, Isabelle ^a   Mfopou, Josue K ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELL TRANSPLANTATION; DIABETES MELLITUS; ENDOCRINE CELL; HUMAN; METABOLIC DISORDER; METABOLIC REGULATION; PANCREAS DISEASE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATION; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; PANCREAS; REGENERATION; STEM CELLS;

EID: 84884594497     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.145     Document Type: Review

References (116)

1. Weir, G. C. & Bonner-Weir, S. Islet β-cell mass in diabetes and how it relates to function, birth, and death. Ann. NY Acad. Sci. 1281, 92-105 (.2013
2. Butler, A. E. et al. Modestly increased β-cell apoptosis but no increased β-cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50, 2323-2331 (.2007
3. Gepts, W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14, 619-633 (.1965
4. Pipeleers, D. & Ling, Z. Pancreatic β cells in insulin-dependent diabetes. Diabetes Metab. Rev. 8, 209-227 (.1992
5. American diabetes association. Diagnosis and classification of diabetes mellitus. Diabetes Care 36 (.Suppl. 1), S67-S74 (.2013
6. Butler, A. E. et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110 (.2003
7. Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C. & Henquin, J. C. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 10 (.Suppl. 4), 32-42 (.2008
8. [No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N. Engl. J. Med. 329, 977-986 (.1993
9. Keymeulen, B. et al. Implantation of standardized β-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41, 452-459 (.1998
10. Ryan, E. A. et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710-719 (.2001
11. Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238 (.2000
12. Keymeulen, B. et al. Correlation between β-cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc. Natl Acad. Sci. USA 103, 17444-17449 (.2006
13. Ryan, E. A. et al. Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060-2069 (.2005
14. Jacobs Tulleneers Thevissen, D. et al. Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of β-cell number and purity. Diabetologia 53, 1690-1699 (.2010
15. van der Windt, D. J., Echeverri, G. J., Ijzermans, J. N. & Cooper, D. K. The choice of anatomical site for islet transplantation. Cell Transplant. 17, 1005-1014 (.2008
16. Parsons, R. F. et al. Murine islet allograft tolerance upon blockade of the B lymphocyte stimulator, BLyS/BAFF. Transplantation 93, 676-685 (.2012
17. Takiishi, T. et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J. Clin. Invest. 122, 1717-1725 (.2012
18. You, S. et al. Induction of allograft tolerance by monoclonal CD3 antibodies: A matter of timing. Am. J. Transplant. 12, 2909-2919 (.2012
19. Tuch, B. E., Hughes, T. C. & Evans, M. D. Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes Metab. Res. Rev. 27, 928-932 (.2011
20. Zhi, Z. L., Khan, F. & Pickup, J. C. Multilayer nanoencapsulation: A nanomedicine technology for diabetes research and management. Diabetes Res. Clin. Pract. 100, 162-169 (.2012
21. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455, 627-632 (.2008
22. Thorel, F. et al. Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature 464, 1149-1154 (.2010
23. Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin promoter factor 1 is required for pancreas development in mice. Nature 371, 606-609 (.1994
24. Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA 97, 1607-1611 (.2000
25. Gittes, G. K. Developmental biology of the pancreas: A comprehensive review. Dev. Biol. 326, 4-35 (.2009
26. Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176-200 (.2004
27. Kim, S. K. & Hebrok, M. Intercellular signals regulating pancreas development and function. Genes Dev. 15, 111-127 (.2001
28. Oliver-Krasinski, J. M. & Stoffers, D. A. On the origin of the β cell. Genes Dev. 22, 1998-2021 (.2008
29. Bhushan, A. et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128, 5109-5117 (.2001
30. Scharfmann, R. Control of early development of the pancreas in rodents and humans: Implications of signals from the mesenchyme. Diabetologia 43, 1083-1092 (.2000
31. Apelqvist, A. et al. Notch signalling controls pancreatic cell differentiation. Nature 400, 877-881 (.1999
32. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (.1981
33. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (.1981
34. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (.1998
35. Lavon, N., Yanuka, O. & Benvenisty, N. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells 24, 1923-1930 (.2006
36. Xu, H. et al. The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improve the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells. Cell Transplant. 22, 147-158 (.2013
37. Hori, Y. et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 16105-16110 (.2002
38. Lumelsky, N. et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389-1394 (.2001
39. Hansson, M. et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53, 2603-2609 (.2004
40. Rajagopal, J., Anderson, W. J., Kume, S., Martinez, O. I. & Melton, D. A. Insulin staining of ES cell progeny from insulin uptake. Science 299, 363 (.2003
41. Mfopou, J. K., Chen, B., Sui, L., Sermon, K. & Bouwens, L. Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes 59, 2094-2101 (.2010
42. Cai, J. et al. Generation of homogeneous PDX1+ pancreatic progenitors from human ES cell-derived endoderm cells. J. Mol. Cell Biol. 2, 50-60 (.2010
43. D'Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541 (.2005
44. Mfopou, J. K., Chen, B., Mateizel, I., Sermon, K. & Bouwens, L. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology 138, 2233-2245 (.2010
45. Nostro, M. C. et al. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138, 861-871 (.2011
46. Xu, X., Browning, V. L. & Odorico, J. S. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech. Dev. 128, 412-427 (.2011
47. Kelly, O. G. et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 29, 750-756 (.2011
48. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (.2008
49. Rezania, A. et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016-2029 (.2012
50. Sui, L., Mfopou, J. K., Chen, B., Sermon, K. & Bouwens, L. Transplantation of human embryonic stem cell-derived pancreatic endoderm reveals a site-specific survival, growth and differentiation. Cell Transplant. 22, 821-830 (.2013
51. Cheng, X. et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 10, 371-384 (.2012
52. Sneddon, J. B., Borowiak, M. & Melton, D. A. Self-renewal of embryonic stem cell-derived progenitors by organ-matched mesenchyme. Nature 491, 765-768 (.2012
53. Sui, L., Geens, M., Sermon, K., Bouwens, L. & Mfopou, J. K. Role of BMP signaling in pancreatic progenitor differentiation from human embryonic stem cells. Stem Cell Rev. http://dx.doi.org/10.1007/s12015-013-9435-6.
54. Schulz, T. C. et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 7, e37004 (.2012
55. Richards, M., Fong, C. Y., Chan, W. K., Wong, P. C. & Bongso, A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936 (.2002
56. Singh, A. M. et al. Signaling network crosstalk in human pluripotent cells: A Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 10, 312-326 (.2012
57. Kunisada, Y., Tsubooka-Yamazoe, N., Shoji, M. & Hosoya, M. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res. 8, 274-284 (.2012
58. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (.2007
59. Zhang, D. et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19, 429-438 (.2009
60. Chou, B. K. et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 21, 518-529 (.2011
61. Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458-466 (.2013
62. Puri, M. C. & Nagy, A. Concise review: Embryonic stem cells versus induced pluripotent stem cells: The game is on. Stem Cells 30, 10-14 (.2012
63. Dor, Y., Brown, J., Martinez, O. I. & Melton, D. A. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46 (.2004
64. Nakamura, K. et al. Pancreatic β-cells are generated by neogenesis from non β cells after birth. Biomed. Res. 32, 167-174 (.2011
65. Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M. & Kushner, J. A. Growth and regeneration of adult β cells does not involve specialized progenitors. Dev. Cell 12, 817-826 (.2007
66. Desai, B. M. et al. Preexisting pancreatic acinar cells contribute to acinar cell, but not islet β cell, regeneration. J. Clin. Invest. 117, 971-977 (.2007
67. Kopinke, D. & Murtaugh, L. C. Exocrine to endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas. BMC Dev. Biol. 10, 38 (.2010
68. Kopp, J. L. et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 138, 653-665 (.2011
69. Kopp, J. L. et al. Identification of Sox9-dependent acinar to ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737-750 (.2012
70. Pan, F. C. et al. Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 140, 751-764 (.2013
71. Solar, M. et al. Pancreatic exocrine duct cells give rise to insulin-producing β cells during embryogenesis but not after birth. Dev. Cell 17, 849-860 (.2009
72. Inada, A. et al. Carbonic anhydrase II positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl Acad. Sci. USA 105, 19915-19919 (.2008
73. Wang, R. N., Kloppel, G. & Bouwens, L. Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 38, 1405-1411 (.1995
74. Erickson, R. P., Grimes, J., Venta, P. J. & Tashian, R. E. Expression of carbonic anhydrase II (.CA II) promoter-reporter fusion genes in multiple tissues of transgenic mice does not replicate normal patterns of expression indicating complexity of CA II regulation in vivo. Biochem. Genet. 33, 421-437 (.1995
75. Furuyama, K. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat. Genet. 43, 34-41 (.2011
76. Kopp, J. L. et al. Progenitor cell domains in the developing and adult pancreas. Cell Cycle 10, 1921-1927 (.2011
77. Xu, X. et al. β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132, 197-207 (.2008
78. Rovira, M. et al. Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc. Natl Acad. Sci. USA 107, 75-80 (.2010
79. Seaberg, R. M. et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22, 1115-1124 (.2004
80. Smukler, S. R. et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell 8, 281-293 (.2011
81. Kopinke, D. et al. Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. Development 138, 431-441 (.2011
82. Russ, H. A., Bar, Y., Ravassard, P. & Efrat, S. In vitro proliferation of cells derived from adult human β-cells revealed by cell-lineage tracing. Diabetes 57, 1575-1583 (.2008
83. Russ, H. A. et al. Insulin-producing cells generated from dedifferentiated human pancreatic β cells expanded in vitro. PLoS ONE 6, e25566 (.2011
84. Bar, Y. et al. Redifferentiation of expanded human pancreatic β cell derived cells by inhibition of the NOTCH pathway. J. Biol. Chem. 287, 17269-17280 (.2012
85. Atouf, F. et al. No evidence for mouse pancreatic β-cell epithelial-mesenchymal transition in vitro. Diabetes 56, 699-702 (.2007
86. Chase, L. G., Ulloa-Montoya, F., Kidder, B. L. & Verfaillie, C. M. Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx 1 or insulin-positive cells. Diabetes 56, 3-7 (.2007
87. Morton, R. A., Geras-Raaka, E., Wilson, L. M., Raaka, B. M. & Gershengorn, M. C. Endocrine precursor cells from mouse islets are not generated by epithelial to mesenchymal transition of mature β cells. Mol. Cell Endocrinol. 270, 87-93 (.2007
88. Weinberg, N., Ouziel-Yahalom, L., Knoller, S., Efrat, S. & Dor, Y. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic β-cells. Diabetes 56, 1299-1304 (.2007
89. Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic β-cell dedifferentiation as a mechanism of diabetic β-cell failure. Cell 150, 1223-1234 (.2012
90. Houbracken, I. & Bouwens, L. The quest for tissue stem cells in the pancreas and other organs, and their application in β-cell replacement. Rev. Diabet. Stud. 7, 112-123 (.2010
91. Nombela-Arrieta, C., Ritz, J. & Silberstein, L. E. The elusive nature and function of mesenchymal stem cells. Nat. Rev. Mol. Cell Biol. 12, 126-131 (.2011
92. Lee, V. M. & Stoffel, M. Bone marrow: An extra-pancreatic hideout for the elusive pancreatic stem cell? J. Clin. Invest. 111, 799-801 (.2003
93. Ianus, A., Holz, G. G., Theise, N. D. & Hussain, M. A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111, 843-850 (.2003
94. Taneera, J. et al. Failure of transplanted bone marrow cells to adopt a pancreatic β-cell fate. Diabetes 55, 290-296 (.2006
95. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (.2002
96. Kodama, S., Kuhtreiber, W., Fujimura, S., Dale, E. A. & Faustman, D. L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302, 1223-1227 (.2003
97. Couzin, J. Immunology. Diabetes studies conflict on power of spleen cells. Science 311, 1694 (.2006
98. Mathews, V. et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury. Diabetes 53, 91-98 (.2004
99. Bell, G. I. et al. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev. 21, 97-109 (.2012
100. Hess, D. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763-770 (.2003
101. Fiorina, P., Voltarelli, J. & Zavazava, N. Immunological applications of stem cells in type 1 diabetes. Endocr. Rev. 32, 725-754 (.2011
102. Nicholas, C. R. & Kriegstein, A. R. Regenerative medicine: Cell reprogramming gets direct. Nature 463, 1031-1032 (.2010
103. Matsuoka, T. A. et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl Acad. Sci. USA 101, 2930-2933 (.2004
104. Sapir, T. et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc. Natl Acad. Sci. USA 102, 7964-7969 (.2005
105. Lima, M. J. et al. Suppression of epithelial to mesenchymal transitioning (.EMT) enhances ex vivo reprogramming of human exocrine pancreatic tissue towards functional insulin producing β-like cells. Diabetes http://dx.doi.org/10.2337/db12-1256.
106. Baeyens, L. et al. In vitro generation of insulin-producing β cells from adult exocrine pancreatic cells. Diabetologia 48, 49-57 (.2005
107. Minami, K. et al. Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc. Natl Acad. Sci. USA 102, 15116-15121 (.2005
108. Baeyens, L. et al. Notch signaling as gatekeeper of rat acinar to β-cell conversion in vitro. Gastroenterology 136, 1750-1760.e13 (.2009
109. Pinho, A. V. et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 60, 958-966 (.2011
110. Lardon, J. et al. Plasticity in the adult rat pancreas: Transdifferentiation of exocrine to hepatocyte-like cells in primary culture. Hepatology 39, 1499-1507 (.2004
111. Hansen, J. B. et al. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β-cell fate in response to cytokines. Cell Metab. 16, 449-461 (.2012
112. Houbracken, I. et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology 141, 731-741 (.2011
113. Collombat, P. et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into α and subsequently β cells. Cell 138, 449-462 (.2009
114. Bramswig, N. C. et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J. Clin. Invest. 123, 1275-1284 (.2013
115. Lanza, R. P., Hayes, J. L. & Chick, W. L. Encapsulated cell technology. Nat. Biotechnol. 14, 1107-1111 (.1996
116. Dean, S. K., Yulyana, Y., Williams, G., Sidhu, K. S. & Tuch, B. E. Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation 82, 1175-1184 (.2006